85. 特発性間質性肺炎 Idiopathic interstitial pneumonia Clinical trials / Disease details

臨床試験数 : 627 / 薬物数 : 443 - (DrugBank : 120) / 標的遺伝子数 : 99 - 標的パスウェイ数 : 212

3 trials found

diseases per page:

Showing 1 to 3 of 3 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05241275 (ClinicalTrials.gov)	July 19, 2022	3/2/2022	Xenon MRI and Progressive ILD	XENON ILD: 129Xe MRI to Evaluate aNtifibrotic respOnse and progressioN in ILD	Idiopathic Pulmonary Fibrosis;Progressive Pulmonary Fibrosis	Drug: Hyperpolarized 129 Xenon Gas Comparing Progressive Pulmonary Fibrosis Treatment	Duke University	Boehringer Ingelheim	Recruiting	18 Years	N/A	All	75	Phase 2	United States
2	NCT04071769 (ClinicalTrials.gov)	August 3, 2020	9/8/2019	Genentech Xenon MRI Idiopathic Pulmonary Fibrosis	Using Xenon MRI to Evaluate the Efficacy of Therapies for Idiopathic Pulmonary Fibrosis	Idiopathic Pulmonary Fibrosis	Drug: Hyperpolarized 129 Xenon Gas Comparing Idiopathic Pulmonary Fibrosis (IPF) Treatment	Duke University	NULL	Recruiting	18 Years	N/A	All	20	Phase 2	United States
3	NCT02478268 (ClinicalTrials.gov)	May 2015	16/6/2015	Using MRI to Visualize Regional Therapy Response in Idiopathic Pulmonary Fibrosis	Using MRI to Visualize Regional Therapy Response in Idiopathic Pulmonary Fibrosis	Idiopathic Pulmonary Fibrosis	Drug: Hyperpolarized 129-Xenon gas;Device: MRI	Bastiaan Driehuys	University of Wisconsin, Madison;National Heart, Lung, and Blood Institute (NHLBI)	Completed	18 Years	N/A	All	64	Phase 1	United States

First Previous1Next Last